Portal Venous 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Infusion Overcomes Hyperinsulinemic Suppression of Endogenous Glucose Output

Portal Venous 5-Aminoimidazole-4-Carboxamide-1-β- d -Ribofuranoside Infusion Overcomes Hyperinsulinemic Suppression of Endogenous Glucose Output Raul C. Camacho , R. Richard Pencek , D. Brooks Lacy , Freyja D. James , E. Patrick Donahue and David H. Wasserman From the Department of Molecular Physiol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2005-02, Vol.54 (2), p.373-382
Hauptverfasser:	CAMACHO, Raul C, PENCEK, R. Richard, LACY, D. Brooks, JAMES, Freyja D, DONAHUE, E. Patrick, WASSERMAN, David H
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminoimidazole Carboxamide - administration & dosage Aminoimidazole Carboxamide - analogs & derivatives Aminoimidazole Carboxamide - pharmacology Animals Biological and medical sciences Blood Glucose - drug effects Blood Glucose - metabolism Care and treatment Complications and side effects Diabetes Diabetes. Impaired glucose tolerance Dogs Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Glucose Clamp Technique Hepatic Veins Hyperinsulinism - prevention & control Infusions, Intravenous Male Medical sciences Portal Vein Ribonucleotides - administration & dosage Ribonucleotides - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!